New Trial to Test Red Wine Compound's Role in Preventing Bowel Cancer

The Colo-Prevent trial will explore the effects of resveratrol, alongside other treatments, on reducing cancer risk in high-risk patients.

The trial will involve 1,300 participants aged 50-73 who have bowel polyps, a precursor to cancer, identified through NHS screenings.
Participants will be administered resveratrol, aspirin, metformin, or a placebo to evaluate their effects on preventing polyp regrowth.
Resveratrol, a compound found in red grapes and other plants, has shown potential in past studies to slow tumor growth.
The trial, led by Professor Karen Brown at the University of Leicester, is one of the largest of its kind focused on cancer prevention.
Results could pave the way for new preventative treatments available to those at high risk of developing bowel cancer.